Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysis

Fig. 2

Meta-analysis on the relationship between mTOR/p-mTOR expression and clinicopathological characteristics of ESCC, including (a) differentiation degree, (b) tumor invasion, (c) TNM stage, (d) LNM and (e) genders. CI, confidence interval; ESCC, esophageal squamous cell carcinoma; LNM, lymph node metastasis; mTOR, mammalian target of rapamycin; p-mTOR, phosphorylated mammalian target of rapamycin; OR, odds ratio

Back to article page